middle.news
How Is ACL Growing Earnings Despite Revenue Dip and Rising Wage Costs?
8:18am on Monday 16th of February, 2026 AEDT
•
Healthcare
Read Story
How Is ACL Growing Earnings Despite Revenue Dip and Rising Wage Costs?
8:18am on Monday 16th of February, 2026 AEDT
Key Points
1H26 revenue down 1.0% due to subdued market growth and contract optimisation
Underlying EBIT rose 2.4%, underlying NPAT up 8.9%, margins expanded by 30 basis points
Interim fully franked dividend increased to 3.75 cents per share; ongoing share buyback
FY26 guidance updated with revenue $735m-$745m and EBIT $66m-$69m, factoring $1.8m wage cost impact
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Australian Clinical Labs (ASX:ACL)
OPEN ARTICLE